Form 4 for INAB IN8BIO, INC.
Accepted 2022-08-18 00:00:00 ET · period of report 2022-08-16 · accession 0001209191-22-046616 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-08-18 | 2022-08-16 | INAB | Transcend Partners Opportunity Fund LLC | 10% | P - Purchase | $1.90 | +789.5K | 4.11M | +24% | +$1.50M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-16 | P | A | 789,473 | $1.90 | 4,111,958 | I See footnote | — | — | (F1) The securities are held by Transcend Partners Opportunity Fund LLC ("Transcend"). Emily Fairbairn is the sole managing member of Transcend and has voting and investment power over the shares held by Transcend. |